-
1دورية أكاديمية
المؤلفون: Karel Pavelka, Zoltán Szekanecz, Nemanja Damjanov, Branimir Anić, Matija Tomšič, Vadim Mazurov, Marija Maksimovic, Orsolya Nagy, Jerzy Świerkot, Tzvetanka Petranova, Tiina Veldi, Asta Baranauskaitė, Catalin Codreanu, Daina Andersone, Roy Fleischmann
المصدر: Drugs in Context, Vol 9, Pp 1-15 (2020)
مصطلحات موضوعية: eastern europe, rheumatoid arthritis, safety, treatment efficacy, upadacitinib, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
2
المؤلفون: Daina Andersone, Tzvetanka Petranova, Matija Tomšič, Orsolya Nagy, Branimir Anić, Tiina Veldi, Karel Pavelka, Nemanja Damjanov, Roy Fleischmann, Jerzy Świerkot, Zoltán Szekanecz, Mazurov Vi, Marija Maksimovic, Asta Baranauskaitė, Catalin Codreanu
المصدر: Drugs in Context, Vol 9, Pp 1-15 (2020)
مصطلحات موضوعية: musculoskeletal diseases, rheumatoid arthritis, safety, medicine.medical_specialty, Placebo, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, treatment efficacy, law, Internal medicine, Post-hoc analysis, medicine, Adalimumab, 030212 general & internal medicine, 030203 arthritis & rheumatology, Pharmacology, business.industry, eastern europe, lcsh:RM1-950, General Medicine, medicine.disease, Rheumatology, upadacitinib, 3. Good health, Eastern european, lcsh:Therapeutics. Pharmacology, Rheumatoid arthritis, Molecular Medicine, Methotrexate, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3de042c830d34df20d08bd6ee9927953
https://www.drugsincontext.com/upadacitinib-versus-placebo-or-adalimumab-with-background-methotrexate-in-patients-with-rheumatoid-arthritis-and-an-inadequate-response-to-methotrexate -
3
المؤلفون: Karel, Pavelka, Zoltán, Szekanecz, Nemanja, Damjanov, Branimir, Anić, Matija, Tomšič, Vadim, Mazurov, Marija, Maksimovic, Orsolya, Nagy, Jerzy, Świerkot, Tzvetanka, Petranova, Tiina, Veldi, Asta, Baranauskaitė, Catalin, Codreanu, Daina, Andersone, Roy, Fleischmann
المصدر: Drugs in Context
مصطلحات موضوعية: musculoskeletal diseases, rheumatoid arthritis, safety, treatment efficacy, Eastern Europe, upadacitinib, Original Research
URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::5d36d2db92403b571ec0a321ffc99121
https://pubmed.ncbi.nlm.nih.gov/33123205 -
4
المؤلفون: Tiina Veldi, Jana Skoupa, Nemanja Damjanov, Predrag Djukic, Sonja Praprotnik, Jelena Vojinovic, Małgorzata Tłustochowicz, Tonu Peets, Ruxandra Ionescu, Catalin Codrenau, Evgeny Nasonov, I. Ancuta, Rasho Rashkov, Matija Tomšič, Lubomir Marinchev, Ewa Orlewska, Branimir Anić, Witold Tłustochowicz, Piotr Wiland
المصدر: Scopus-Elsevier
Medical Science Monitor : International Medical Journal of Experimental and Clinical Researchمصطلحات موضوعية: rheumatoid arthritis, medicine.medical_specialty, Health Planning Guidelines, Short Report, Alternative medicine, Arthritis, Biologic treatment, Health Services Accessibility, biologic treatment, Arthritis, Rheumatoid, medicine, Humans, Intensive care medicine, business.industry, General Medicine, medicine.disease, guideline, health services accessibility, Biological Therapy, Europe, Eastern european, Antirheumatic Agents, Rheumatoid arthritis, Costs and Cost Analysis, Physical therapy, Health Expenditures, business, Delivery of Health Care, hormones, hormone substitutes, and hormone antagonists
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5797afe0c1723857d83843c42ad71e8b
https://doi.org/10.12659/msm.935624